Donepezil Tablet
Product Images NDC 70518-4380

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Donepezil (NDC 70518-4380). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Donepezilfigure10 (Donepezilfigure10)

FDA Label Image

Donepezilfigure8 (Donepezilfigure8)

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Figure5 (Figure5)

FDA Label Image

Figure6 (Figure6)

FDA Label Image

Figure7 (Figure7)

FDA Label Image

Figure9 (Figure9)

FDA Label Image

Remedy_label (Remedy Label)

This is a description for Donepezil HCI 5mg tablets. The tablets are white and round, with a quantity of 90 tablets per bottle. The NDC number is 70518-4380-00. The medication is to be kept out of the reach of children and stored at 20-25°C (68-77°F) with permitted excursions to 15-30°C (59-86°F). The manufacturer is Camber Pharma, Inc., located in Piscataway, NJ. The medication is for the use of the patient it was prescribed to, and the usual dosage instructions can be found in the insert.*

FDA Label Image

Donepezilfigure11 (Donepezilfigure11)

FDA Label Image

Donepezilfigure12 (Donepezilfigure12)

This text provides information on the Cumulative Percentage of Patients, specifically related to SIB (Self-Injurious Behavior) Change from Baseline. It includes numerical data points and indicates the percentage of patients falling within different ranges. The percentages are shown on a scale with values ranging from -60% to 50%, establishing a visualization of patient distribution.*

FDA Label Image

Donepezilfigure13 (Donepezilfigure13)

This text provides dosage information for Donepezil Hydrochloride, with a comparison of the effects on patients at two different doses (23mg/day and 10mg/day) based on the CIBIC-plus rating scale. The scale measures the level of improvement or worsening in patients' conditions after treatment with Donepezil.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.